InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.35
(
-0.29%
)
Bitcoin
61,321.55
(
0.86%
)
Post# of 30990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

LutherTiggs

Send PM Follow Ignore
Followers 22
Posts 1717
Boards Moderated 0
Alias Born 10/22/2013

LutherTiggs

Re: leifsmith post# 27987

Wednesday, 02/15/2017 3:55:26 PM

Wednesday, February 15, 2017 3:55:26 PM

Post# of 30990
Well, I have lots of questions. Is Dr. Mullan as CEO of Archer Pharmaceuticals using or benefiting for research done at RCPI on "our" (common shareholders) dime? Where is Ryan Lanier who was Chief Science Officer at RCPI now? (his LinkedIn still shows him in position at RCPI...I guess he has not updated). Ted Jenkins is now working for CrossBio Development, LLC. Still have to believe that the people that did the last financing expect to realize at least something from the IP sale. Who is working on establishing value of the sale?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up